Researchers say a new drug may be a breakthrough in the treatment of Hodgkin's Lymphoma. According to the study, published in the New England Journal of Medicine, the drug Nivolumab could be an effective means of treating the cancer in patients whose disease does not respond to chemotherapy or stem cell transplants.
http://ift.tt/1ADXUH9
http://ift.tt/1ADXUH9
No comments:
Post a Comment